Trial record 1 of 1 for:    NCT01262365
Previous Study | Return to List | Next Study

Study of Epratuzumab Versus Placebo in Subjects With Moderate to Severe General Systemic Lupus Erythematosus (EMBODY 1)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01262365
Recruitment Status : Completed
First Posted : December 17, 2010
Last Update Posted : February 5, 2016
Information provided by (Responsible Party):
UCB Pharma